TAUNS Laboratories, Inc.
197A.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | ¥58 | ¥55 | ¥51 | ¥63 |
| - Cash | ¥5 | ¥9 | ¥9 | ¥8 |
| + Debt | ¥20 | ¥14 | ¥14 | ¥13 |
| Enterprise Value | ¥73 | ¥60 | ¥56 | ¥69 |
| Revenue | ¥2 | ¥1 | ¥6 | ¥6 |
| % Growth | 132.2% | -81.9% | 1.2% | – |
| Gross Profit | ¥2 | ¥0 | ¥4 | ¥4 |
| % Margin | 68.8% | 8.8% | 70.5% | 70.3% |
| EBITDA | ¥1 | -¥1 | ¥3 | ¥3 |
| % Margin | 31.2% | -85.8% | 53.1% | 53.4% |
| Net Income | ¥0 | -¥0 | ¥2 | ¥2 |
| % Margin | 15.1% | -32.4% | 34.8% | 35.8% |
| EPS Diluted | 3.33 | -3.05 | 17.94 | 18.55 |
| % Growth | 209.2% | -117% | -3.3% | – |
| Operating Cash Flow | – | ¥0 | ¥0 | ¥0 |
| Capital Expenditures | – | ¥0 | ¥0 | ¥0 |
| Free Cash Flow | – | ¥0 | ¥0 | ¥0 |